Evaxion to Present New Preclinical Data for AI-Designed CMV Vaccine Candidate
Evaxion's EVX-V1 vaccine candidate uses an AI-driven, multi-antigen approach to target cytomegalovirus — a leading cause of congenital hearing loss.
Evaxion's EVX-V1 vaccine candidate uses an AI-driven, multi-antigen approach to target cytomegalovirus — a leading cause of congenital hearing loss.
Are you and your staff prepared for unexpected health events at work?
The FCC-certified captioning app's AI-powered TTS features earned the company the "Text to Speech Solution of the Year" recognition in the ninth annual AI Breakthrough Awards program.
Oticon is accepting nominations for its annual awards program recognizing individuals with hearing loss and the professionals, caregivers, and educators who champion hearing health.
From building rapport to leveraging technology, HCPs share creative strategies to keep kids engaged for successful pediatric testing.
Hearing practices often lose prospective patients not because of a lack of leads, but because inconsistent and unstructured follow-up processes allow interested patients to disengage before receiving care.